|
PTDSS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.598900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.751800E-02 |
| Normal-vs-Stage2 |
4.227000E-01 |
| Normal-vs-Stage3 |
2.757600E-03 |
| Normal-vs-Stage4 |
7.377100E-04 |
| Stage1-vs-Stage2 |
4.588200E-01 |
| Stage1-vs-Stage3 |
1.337000E-01 |
| Stage1-vs-Stage4 |
4.910100E-02 |
| Stage2-vs-Stage3 |
1.080010E-01 |
| Stage2-vs-Stage4 |
4.079600E-02 |
| Stage3-vs-Stage4 |
6.163200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.544800E-03 |
| Normal-vs-AfricanAmerican |
1.698150E-01 |
| Normal-vs-Asian |
1.270140E-02 |
| Caucasian-vs-AfricanAmerican |
6.657200E-01 |
| Caucasian-vs-Asian |
9.008800E-01 |
| AfricanAmerican-vs-Asian |
5.989200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.842100E-02 |
| Normal-vs-Female |
3.801700E-03 |
| Male-vs-Female |
5.960200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.316400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.139300E-03 |
| Normal-vs-Age(61-80Yrs) |
7.368500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.933170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.601400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.136600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.322600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.142400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.341000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.706400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.620880E-04 |
| Classical-VS-Follicular |
7.815700E-03 |
| Classical-VS-Other |
8.950800E-01 |
| Classical-VS-Normal |
7.476100E-03 |
| Tall-VS-Follicular |
1.15329999994529E-06 |
| Tall-VS-Other |
3.374000E-01 |
| Tall-VS-Normal |
3.86890000036999E-07 |
| Follicular-VS-Other |
5.085200E-01 |
| Follicular-VS-Normal |
6.553600E-01 |
| Other-VS-Normal |
6.422000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.971370E-01 |
| Normal-vs-N1 |
4.86789999976089E-07 |
| N0-vs-N1 |
2.0245999999946E-05 |
|
|
